KCM
COLL icon

Kendall Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Kendall Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Buy
34,730
+18,465
+114% +$631K 0.21% 111
2026
Q1 		$538K Sell
16,265
-325
-2% -$13.8K 0.11% 153
2025
Q4 		$768K Sell
16,590
-1,390
-8% -$58.2K 0.16% 132
2025
Q3 		$629K Hold
17,980
– – 0.14% 138
2025
Q2 		$532K Sell
17,980
-2,380
-12% -$67.9K 0.14% 144
2025
Q1 		$608K Buy
20,360
+2,600
+15% +$79.5K 0.18% 134
2024
Q4 		$509K Buy
17,760
+4,260
+32% +$141K 0.15% 147
2024
Q3 		$522K Buy
+13,500
New +$481K 0.16% 144

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Kendall Capital Management's COLL Position: Q2 2026 in Review

Kendall Capital Management increased its Collegium Pharmaceutical (COLL) stake by 114% in Q2 2026, buying an estimated $631K and bringing the position to 34,730 shares worth $1.26M. The position accounts for 0.21% of the portfolio, ranked #111.

Kendall Capital Management first reported a position in COLL in Q3 2024 and has held it in 8 quarters since. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Kendall Capital Management held 34,730 shares of Collegium Pharmaceutical worth $1.26M as of Q2 2026.
  • Kendall Capital Management bought 18,465 Collegium Pharmaceutical shares in Q2 2026, an estimated $631K.
  • Collegium Pharmaceutical made up 0.21% of Kendall Capital Management's portfolio in Q2 2026, its #111 holding.
  • Kendall Capital Management first reported a position in Collegium Pharmaceutical in Q3 2024 and has held it in 8 quarters since.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Kendall Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.